Global Coronary Stents Market 2017-2021
About Coronary Stents
Coronary artery disease (CAD) or atherosclerotic heart disease is a type of heart disease that is associated with the hardening of the arteries due to the accumulation of fatty compounds, cholesterol, calcium, and other blood clotting materials in and around the artery wall. These lesions, if become unstable or clinically significant, are treated with PCI, which require balloon angioplasty and stent implantation. Coronary stents or cardiac stents are small, expandable tube-shaped devices made of stainless steel, which are placed in the artery for easy blood flow during the treatment of CAD.
Technavio’s analysts forecast the global coronary stents market to grow at a CAGR of 5.61% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global coronary stents market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of coronary stents.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Coronary Stents Market 2017-2021
Technavio recognizes the following companies as the key players in the global coronary stents market: bbott Laboratories, Boston Scientific, and Medtronic
Other Prominent Vendors in the market are: Shandong JW Medical Systems, Biosensors International, Opto Circuits, Cook Medical, Elixir Medical, Envision Scientific, LEPU MEDICAL, and Meril Life Sciences
Commenting on the report, an analyst from Technavio’s team said: “A hybrid procedure is one of the new treatment methods that combines minimally invasive coronary artery bypass surgery (MICABS) with catheter-based coronary intervention. In a bypass surgery, a cardiologist performs angioplasty to restore the normal blood flow in arteries that are not blocked enough to require a bypass. To reduce the chance of re-blockage of the artery, a BMS or DES is used. This method helps to eliminate the plaque deposition in the blood vessels and has fewer after-effects. Since a hybrid procedure involves stenting and a bypass in a single operation, it is cost-effective. This procedure cannot be performed in all cases; the individuals have to be monitored for distal left main coronary artery or proximal left anterior descending CAD, diabetes, systolic dysfunction, surgical risk, and coronary anatomy.”
According to the report, generally, CROs conduct clinical trials to evaluate the safety and efficacy of coronary stents. However, these organizations are now helping manufacturers in developing these devices. They are also engaging in tie-ups with regulatory agencies for pre- and post-market approvals of stents, which help to minimize the duration of regulatory approvals.
Further, the report states that the development of laser angiography or laser ablation has brought a new and promising treatment for atherosclerosis plaque. Different laser beams like xenon chloride excimer laser, argon, and neodymium: yttrium aluminum garnet with different wavelengths, frequencies, and pulse durations can remove obstructions with minimal damage to the adjacent vessel walls.
Find more reports on related topics - https://www.spendedge.com/
bbott Laboratories, Boston Scientific, Medtronic, Shandong JW Medical Systems, Biosensors International, Opto Circuits, Cook Medical, Elixir Medical, Envision Scientific, LEPU MEDICAL, and Meril Life Sciences
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook